Skip to Content

Meeting Information

EDUCATIONAL POLICY COMMITTEE

Thursday, January 18, 2001

6:15 — 6:25 p.m.

Saturday, January 20, 2001

9:45 — 10:30 a.m.

Board Room, The Rotunda


Committee Members:

T. Keister Greer, Chair

Elsie Goodwyn Holland Walter F. Walker

Stephen S. Phelan, Jr. Joseph E. Wolfe

Elizabeth A. Twohy John P. Ackerly, III, Ex Officio

AGENDA

I. CONSENT AGENDA (Mr. Low) (Thursday)

    1. Department Name Changes, School ofEngineering and Applied Science
    2. Conflict of Interest Exemption (MonicAid Corporation)
    • Fiscal Impact Statement 5
    1. Conflict of Interest Exemption (DVTI, Incorporated)
    • Fiscal Impact Statement 9

II. REPORTS BY THE VICE PRESIDENT AND PROVOST (Saturday) (Mr. Low)

    1. Vice President’s Remarks
    2. Progress Report on Virginia 2020 Commissions (Mr. Low to introduce Ms. Laurie P. Kelsh; Ms. Kelsh to report)

C. Faculty Senate (Mr. Low to introduce 13 Ms. Patricia H. Werhane; Ms. Werhaneto report)

D. Library of Tomorrow (Mr. Low to introduce Ms. Karin Wittenborg; Ms. Wittenborg toReport)


III.FACULTY PERSONNEL ACTIONS

* For consideration in Executive Session

UNIVERISTY OF VIRGINIA

BOARD OF VISITORS AGENDA ITEM SUMMARY

AGENDA ITEM:I.A. Department Name Changes, School of Engineering and Applied Science

BACKGROUND: The School of Engineering and Applied Science has proposed name changes for two departments.

DISCUSSION: We have approved internally the School’s proposal that the Department of Electrical Engineering be changed to the Department of Electrical and Computer Engineering, and the Department of Systems Engineering be changed to the Department of Systems and Information Engineering. Both changes are being made in order more accurately to reflect the mission, teaching and research interests of the departments. We have forwarded this proposal to the State Council of Higher Education, where it will receive automatic approval from Council staff, as it will be treated as an item "for purposes of internal management only."

ACTION REQUIRED: This item requires no action by the Board. It is on the Agenda simply as a report to the Board of an action taken.

 

AGENDA ITEM:I.B. Conflict of Interest Exemption

(MonicAid Corporation)

BACKGROUND: The School of Medicine is negotiating a sponsored research contract with MonicAid Corporation, a Virginia biotechnology company created on July 28, 2000, to support research aimed at investigating the protective effect of IgM autoantibodies in retarding development of AIDS after an HIV-1 infection.

DISCUSSION: One University faculty member, Peter I. Lobo, M.D., and members of his family own in excess of three percent of the equity in the company. Under the Virginia Conflict of Interests Act, the University’s contracting with MonicAid Corporation would place Dr. Lobo in violation of the Act, unless the Board of Visitors approves the conflict created by his and his family members’ equity interest. State law grants such approval authority to the Board in the case of sponsored research, in order to allow research furthering the public interest.

Virginia law and University of Virginia policy will require Dr. Lobo to file annual disclosure statements of his and his family members’ economic interests in the company. Dr. Lobo will not be involved in the University’s negotiation, approval, or procurement of contract terms with MonicAid Corporation. The chair of the Department of Internal Medicine heads a University oversight team responsible for managing and overseeing the research, including independently supervising, evaluating, and making personnel decisions, to ensure that the continuing best interests of the University are served. As an additional precaution, the chair will report at least each quarter to the Dean of the School of Medicine on the progress of sponsored research activity and the utilization of University resources.

ACTION REQUIRED: Approval by the Educational Policy Committee and the Board of Visitors.

 

UNIVERSITY OF VIRGINIA

FISCAL IMPACT STATEMENT

PROJECT/PROPOSED BOARD OF VISITORS ACTION: Approval to enter into sponsored research contracts with MonicAid Corporation

DESCRIPTION: The School of Medicine is negotiating a sponsored research contract with MonicAid Corporation, a Virgina biotechnology start-up company created in July 2000. The founding members of MonicAid Corporation include a University of Virginia faculty member.

One faculty member and members of his family own a total of 88.5 percent equity in the company. Under the Virginia Conflict of Interests Act, the School of Medicine may enter into a research contract with MonicAid Corporation without placing the faculty member in violation of the Act, if the Board of Visitors approves the conflict created by his and his family’s ownership in excess of three percent.

The research contract would help fund research to investigate the role of human IgM antibodies to chemokine receptors in HIV and AIDS.

FISCAL IMPACT: Fiscal impact is negligible.

CONCLUSION: It is recommended that the Board of Visitors permit the University to negotiate and enter into the proposed contract with MonicAid Corporation to investigate the role of human IgM antibodies to chemokine receptors in HIV and AIDS.

RECOMMEND APPROVAL OF BOARD ACTION:

__________________________

Leonard W. Sandridge

January 18, 2001

 

AGENDA ITEM:I.C. Conflict of Interest Exemption

(DVTI, Incorporated)

BACKGROUND: The University of Virginia is negotiating a contract with Directed Vapor Technologies International, Incorporated (DVTI, Inc.), a Delaware company created on June 1, 2000 to support commercialization of University of Virginia technology related to directed vapor deposition which has been licensed to DVTI, Inc. for commercialization.

DISCUSSION: Three University faculty members, James Groves, Douglas Queheillalt and Derek Haas each own in excess of three percent of the equity in the company. Under the Virginia Conflict of Interests Act, the University’s contracting with DVTI, Inc. would place all three in violation of the Act, unless the Board of Visitors approves the conflict created by their equity interest. State law grants such approval authority to the Board in the case of contracts which support commercialization of University intellectual property.

Virginia law and University of Virginia policy will require James Groves, Douglas Queheillalt and Derek Haas to file annual disclosure statements of their economic interests in the company. None of these faculty will be involved in the University’s negotiation, approval, or procurement of contract terms with DVTI, Inc. The chair of the Department of Materials Science and Engineering will head a University oversight team responsible for managing and overseeing the contract to ensure that the continuing best interests of the University are served. As an additional precaution, the chair will report at least each quarter to the Dean of the School of Engineering and Applied Science on the progress of the commercialization efforts and the utilization of University resources.

ACTION REQUIRED: Approval by the Educational Policy Committee and the Board of Visitors.

 

UNIVERSITY OF VIRGINIA

FISCAL IMPACT STATEMENT

PROJECT/PROPOSED BOARD OF VISITORS ACTION: Approval to enter into contracts with Directed Vapor Deposition International, Incorporated.

DESCRIPTION: The University of Virginia is negotiating a contract with DVTI, Incorporated, a Delaware start-up company created in June 2000 to commercialize University of Virginia intellectual property in the field of vapor deposition. The Corporation includes three University of Virginia faculty members.

Each of the three faculty members owns more than 3 percent equity in the company. Under the Virginia Conflict of Interests Act, the University of Virginia may enter into a contract with DVTI, Incorporated without placing the faculty members in violation of the Act, if the Board of Visitors approves the conflict created by their ownership in excess of three percent.

The contract would reimburse the University for the use of an advanced vapor deposition device to permit DVTI, Incorporated to test some commercial samples.

FISCAL IMPACT: Fiscal impact is negligible. However, successful commercialization of this technology could provide substantial returns to the University from royalty income.

CONCLUSION: It is recommended that the Board of Visitors permit the University to negotiate and enter into the proposed contract with DVTI, Incorporated to test samples of commercial materials.

RECOMMEND APPROVAL OF BOARD ACTION:

__________________________

Leonard W. Sandridge

January 18, 2001

 

AGENDA ITEM:II.A. Vice President’s Remarks

DISCUSSION: The Vice President and Provost will use this portion of the Educational Policy Committee to inform the Board of Visitors of recent events of which the Board should be made aware.

ACTION REQUIRED: None

 

AGENDA ITEM: II.B. Progress Report on Virginia 2020 Commissions

DISCUSSION: The Vice President and Provost will introduce The University’s Chief Planning Officer, Ms. Laurie P. Kelsh, who will brief the Board on the progress of the Virginia 2020 Commissions.

ACTION REQUIRED: None


AGENDA ITEM: II.C. Faculty Senate

DISCUSSION: The Vice President and Provost will introduce the Chair of the Faculty Senate, Ms. Patricia H. Werhane, who will give a report to the Board on the Senate’s accomplishments during the fall semester.

ACTION REQUIRED: None

 

AGENDA ITEM: II.D. Library of Tomorrow

DISCUSSION: The Vice President and Provost will introduce Ms. Karin Wittenborg, University Librarian, who will give a report to the Board on the Library of Tomorrow.

ACTION REQUIRED: None

MORE MEETING INFORMATION
PAST MEETINGS

PUBLIC MINUTES

BOARD OF VISITORS OF THE UNIVERSITY OF VIRGINIA

Maintained by sgh4c@virginia.edu
Last Modified: Thursday, 02-Jul-2009 08:09:50 EDT
© 2000 by the Rector and Visitors of the University of Virginia